Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

National Heart, Lung, and Blood Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

National Heart, Lung, and Blood Institute brings 3 presentations to ASH 2026 in New Orleans. Its program spans immune-driven bone marrow failure, research funding for early-career faculty and new endpoints for sickle cell disease trials. It also covers how cells carrying acquired mutations gain ground in immune-mediated marrow failure.

OrganizationASH 2026 Attendance
Government & non-profit
NIH institute that funds and conducts research on heart, lung, blood and sleep disorders, including sickle cell disease.
Talk
Clonal Selection of Somatic Mutations in Immune Mediated BMF
How acquired mutations are selected in immune and inherited bone marrow failure, and how genomic tests can track clones that progress to myeloid cancer.
Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from National Heart, Lung, and Blood Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction